{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:47:03Z","timestamp":1790884023543,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000969","name":"American Institute for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["AI171944-01A1"],"award-info":[{"award-number":["AI171944-01A1"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R21 AI157831-01A1"],"award-info":[{"award-number":["R21 AI157831-01A1"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008065","name":"Georgia Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 CA225784-01"],"award-info":[{"award-number":["U01 CA225784-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010460","name":"US Army Medical Command","doi-asserted-by":"publisher","award":["W81XWH-22-PCRP-EHDA"],"award-info":[{"award-number":["W81XWH-22-PCRP-EHDA"]}],"id":[{"id":"10.13039\/100010460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ymthe.2025.09.045","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:36:55Z","timestamp":1759009015000},"page":"281-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Extracellular vesicle-mediated delivery of CRISPR machinery silences androgen receptor in castration-resistant prostate cancer cells"],"prefix":"10.1016","volume":"34","author":[{"given":"Chenming","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raunak","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0158-1017","authenticated-orcid":false,"given":"Houjian","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.09.045_bib1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12943-021-01431-6","article-title":"Application of the CRISPR\/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer","volume":"20","author":"Zhang","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2025.09.045_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cell.2015.12.041","article-title":"The Heroes of CRISPR","volume":"164","author":"Lander","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.09.045_bib3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tig.2021.02.008","article-title":"DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing","volume":"37","author":"Xue","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.ymthe.2025.09.045_bib4","article-title":"CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation","volume":"15","author":"Liu","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.09.045_bib5","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.7150\/thno.42325","article-title":"Selective targeting of the oncogenic KRAS G12S mutant allele by CRISPR\/Cas9 induces efficient tumor regression","volume":"10","author":"Gao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2025.09.045_bib6","doi-asserted-by":"crossref","first-page":"26027","DOI":"10.18632\/oncotarget.15215","article-title":"The CRISPR\/Cas9 system efficiently reverts the tumorigenic ability of BCR\/ABL in vitro and in a xenograft model of chronic myeloid leukemia","volume":"8","author":"Garcia-Tunon","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2025.09.045_bib7","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1093\/nar\/gkaa683","article-title":"Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR\/Cas9 system for gene therapy","volume":"48","author":"Zhuang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.09.045_bib8","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.apsb.2021.05.020","article-title":"In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges","volume":"11","author":"Behr","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ymthe.2025.09.045_bib9","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41417-023-00597-z","article-title":"Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR\/Cas-mediated cancer therapy","volume":"30","author":"Ahmadi","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ymthe.2025.09.045_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101649","article-title":"CRISPR\/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications","volume":"13","author":"Cheng","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymthe.2025.09.045_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.09.045_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.09.045_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12964-023-01103-6","article-title":"A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication","volume":"21","author":"Liu","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ymthe.2025.09.045_bib14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/10717544.2020.1748758","article-title":"Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source","volume":"27","author":"Meng","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ymthe.2025.09.045_bib15","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41467-020-14957-y","article-title":"Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping","volume":"11","author":"Gee","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.045_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12389","article-title":"Extracellular vesicle-mediated delivery of CRISPR\/Cas9 ribonucleoprotein complex targeting proprotein convertase subtilisin-kexin type 9 (Pcsk9) in primary mouse hepatocytes","volume":"13","author":"Ilahibaks","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2025.09.045_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41467-018-07845-z","article-title":"Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins","volume":"10","author":"Mangeot","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.045_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12196","article-title":"Encapsulating Cas9 into extracellular vesicles by protein myristoylation","volume":"11","author":"Whitley","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2025.09.045_bib19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cell.2015.06.053","article-title":"Integrative Clinical Genomics of Advanced Prostate Cancer","volume":"162","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.09.045_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108255","article-title":"Current and emerging therapies for neuroendocrine prostate cancer","volume":"238","author":"Alabi","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.045_bib21","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/pros.22674","article-title":"Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer","volume":"73","author":"Guerrero","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.ymthe.2025.09.045_bib22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4103\/aja.aja_10_19","article-title":"Current opinion and mechanistic interpretation of combination therapy for castration-resistant prostate cancer","volume":"21","author":"Xu","year":"2019","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.ymthe.2025.09.045_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2025.09.045_bib24","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","article-title":"AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer","volume":"371","author":"Antonarakis","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.09.045_bib25","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.1038\/s41388-020-01479-6","article-title":"Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors","volume":"39","author":"Zhu","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.09.045_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1126\/science.3353727","article-title":"Cloning of human androgen receptor complementary DNA and localization to the X chromosome","volume":"240","author":"Lubahn","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.09.045_bib27","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1210\/er.2007-0019","article-title":"Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex","volume":"28","author":"Heemers","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ymthe.2025.09.045_bib28","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1158\/0008-5472.CAN-24-0890","article-title":"An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression","volume":"84","author":"Shrestha","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2025.09.045_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe1505","article-title":"Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets","volume":"376","author":"Tang","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.09.045_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12343","article-title":"Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing","volume":"12","author":"Whitley","year":"2023","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2025.09.045_bib31","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030452","article-title":"Androgen Signaling in Prostate Cancer","volume":"7","author":"Dai","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ymthe.2025.09.045_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28093698","article-title":"PROTACs in the Management of Prostate Cancer","volume":"28","author":"Yedla","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ymthe.2025.09.045_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107234","article-title":"PROTACs targeting androgen receptor signaling: Potential therapeutic agents for castration-resistant prostate cancer","volume":"205","author":"Zhang","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ymthe.2025.09.045_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104500","article-title":"Targeting androgen receptor and the variants by an orally bioavailable Proteolysis Targeting Chimeras compound in castration resistant prostate cancer","volume":"90","author":"Hung","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2025.09.045_bib35","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000875","article-title":"Exosome-mediated delivery of CRISPR\/Cas9 for targeting of oncogenic Kras(G12D) in pancreatic cancer","volume":"4","author":"McAndrews","year":"2021","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.ymthe.2025.09.045_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2020.07.033","article-title":"Tropism-facilitated delivery of CRISPR\/Cas9 system with chimeric antigen receptor-extracellular vesicles against B-cell malignancies","volume":"326","author":"Xu","year":"2020","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.09.045_bib37","first-page":"75","article-title":"A comprehensive overview of exosomes as drug delivery vehicles\u2014endogenous nanocarriers for targeted cancer therapy","volume":"1846","author":"Johnsen","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2025.09.045_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713247","article-title":"Strategies for Engineering of Extracellular Vesicles","volume":"24","author":"Danilushkina","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.09.045_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.copbio.2018.07.005","article-title":"The influence of eukaryotic chromatin state on CRISPR-Cas9 editing efficiencies","volume":"55","author":"Verkuijl","year":"2019","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.09.045_bib40","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/mt.2010.36","article-title":"LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin","volume":"18","author":"Gijsbers","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.045_bib41","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/epi.10.31","article-title":"Histone modifications and chromatin organization in prostate cancer","volume":"2","author":"Chen","year":"2010","journal-title":"Epigenomics"},{"key":"10.1016\/j.ymthe.2025.09.045_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymthe.2019.10.008","article-title":"Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency","volume":"28","author":"Chung","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.045_bib43","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/1873-3468.12707","article-title":"Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency","volume":"591","author":"Jensen","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2025.09.045_bib44","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12677","article-title":"Nucleosomes impede Cas9 access to DNA in vivo and in vitro","volume":"5","author":"Horlbeck","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2025.09.045_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126397","article-title":"Analysis of NHEJ-Based DNA Repair after CRISPR-Mediated DNA Cleavage","volume":"22","author":"Song","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.09.045_bib46","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1038\/s41467-021-26788-6","article-title":"A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing","volume":"12","author":"Sinha","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.045_bib47","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/jcb.10661","article-title":"Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer","volume":"91","author":"Ghosh","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ymthe.2025.09.045_bib48","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.09.045_bib49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2967\/jnmt.122.263814","article-title":"(177)Lu-PSMA Therapy","volume":"50","author":"Parent","year":"2022","journal-title":"J. Nucl. Med. Technol."},{"key":"10.1016\/j.ymthe.2025.09.045_bib50","article-title":"Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target","volume":"9","author":"Yarahmadi","year":"2022","journal-title":"Mol. Cell. Oncol."},{"key":"10.1016\/j.ymthe.2025.09.045_bib51","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2217\/fon-2019-0635","article-title":"Functionalized nano-targeted moieties in management of prostate cancer","volume":"16","author":"Salaheldin","year":"2020","journal-title":"Future Oncol."},{"key":"10.1016\/j.ymthe.2025.09.045_bib52","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3389\/fonc.2018.00653","article-title":"New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen","volume":"8","author":"Cimadamore","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2025.09.045_bib53","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4161\/cbt.9.5.10891","article-title":"Androgen receptor sequence and variations in several common prostate cancer cell lines","volume":"9","author":"Baum","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.045_bib54","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41388-020-01598-0","article-title":"Loss and revival of androgen receptor signaling in advanced prostate cancer","volume":"40","author":"Formaggio","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.09.045_bib55","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/labinvest.3780190","article-title":"Epigenetic regulation of androgen receptor gene expression in human prostate cancers","volume":"80","author":"Nakayama","year":"2000","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ymthe.2025.09.045_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090002","article-title":"Comparative genomic and transcriptomic analyses of LNCaP and C4-2B prostate cancer cell lines","volume":"9","author":"Spans","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.09.045_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061290","article-title":"Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic Resistance","volume":"13","author":"Lima","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2025.09.045_bib58","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1093\/nar\/gks290","article-title":"An analysis of substitution, deletion and insertion mutations in cancer genes","volume":"40","author":"Iengar","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.09.045_bib59","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41586-018-0409-3","article-title":"Genetic and transcriptional evolution alters cancer cell line drug response","volume":"560","author":"Ben-David","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.09.045_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.96","article-title":"Src family kinases engage differential pathways for encapsulation into extracellular vesicles","volume":"2","author":"Ye","year":"2023","journal-title":"J. Extracell. Biol."},{"key":"10.1016\/j.ymthe.2025.09.045_bib61","article-title":"Hijacking Endocytosis and Autophagy in Extracellular Vesicle Communication: Where the Inside Meets the Outside","volume":"8","author":"Pedrioli","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2025.09.045_bib62","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/febs.15781","article-title":"Protein S-Palmitoylation: advances and challenges in studying a therapeutically important lipid modification","volume":"289","author":"Main","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.ymthe.2025.09.045_bib63","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.omtn.2018.05.010","article-title":"VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9","volume":"12","author":"Montagna","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.09.045_bib64","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00408-020-00408-4","article-title":"ACE2: The Major Cell Entry Receptor for SARS-CoV-2","volume":"198","author":"Scialo","year":"2020","journal-title":"Lung"},{"key":"10.1016\/j.ymthe.2025.09.045_bib65","doi-asserted-by":"crossref","first-page":"79S","DOI":"10.2967\/jnumed.115.170720","article-title":"The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer","volume":"57","author":"Afshar-Oromieh","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ymthe.2025.09.045_bib66","article-title":"Treatment-emergent neuroendocrine prostate cancer: molecularly driven clinical guidelines","volume":"6","author":"Clermont","year":"2019","journal-title":"Int. J. Endocr. Oncol."},{"key":"10.1016\/j.ymthe.2025.09.045_bib67","doi-asserted-by":"crossref","first-page":"41976","DOI":"10.18632\/oncotarget.5659","article-title":"Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancer","volume":"6","author":"Qi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2025.09.045_bib68","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2217\/epi-2023-0374","article-title":"Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell response","volume":"16","author":"Fischetti","year":"2024","journal-title":"Epigenomics"},{"key":"10.1016\/j.ymthe.2025.09.045_bib69","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1093\/nar\/gkz286","article-title":"A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities","volume":"47","author":"Kounatidou","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.09.045_bib70","doi-asserted-by":"crossref","first-page":"6950","DOI":"10.1158\/0008-5472.CAN-17-0981","article-title":"Blocking Myristoylation of Src Inhibits Its Kinase Activity and Suppresses Prostate Cancer Progression","volume":"77","author":"Kim","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2025.09.045_bib71","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1158\/1078-0432.CCR-13-3296","article-title":"Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer","volume":"20","author":"Liu","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.09.045_bib72","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41592-020-01034-x","article-title":"Exosome detection via the ultrafast-isolation system: EXODUS","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2025.09.045_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170628","article-title":"A Comparative Study of Serum Exosome Isolation Using Differential Ultracentrifugation and Three Commercial Reagents","volume":"12","author":"Helwa","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.09.045_bib74","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1016\/j.bbadis.2018.04.016","article-title":"Extracellular vesicle-mediated long-range communication in stressed retinal pigment epithelial cell monolayers","volume":"1864","author":"Shah","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ymthe.2025.09.045_bib75","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Thery","year":"2018","journal-title":"J. Extracell Vesicles"},{"key":"10.1016\/j.ymthe.2025.09.045_bib76","article-title":"Calcium phosphate transfection","author":"Kingston","year":"2003","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.09.045_bib77","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/bioinformatics\/btw561","article-title":"Cas-analyzer: an online tool for assessing genome editing results using NGS data","volume":"33","author":"Park","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2025.09.045_bib78","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-1-4939-3578-9_16","article-title":"Visualizing Genomic Data Using Gviz and Bioconductor","volume":"1418","author":"Hahne","year":"2016","journal-title":"Methods Mol. Biol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625008160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625008160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:31:42Z","timestamp":1783020702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625008160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1525001625008160"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.09.045","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicle-mediated delivery of CRISPR machinery silences androgen receptor in castration-resistant prostate cancer cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.09.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}